Tackling ethical, economical, legal, and social aspects of Personalised Medicine Workshop - Regions4PerMed

While there are more and more Countries introducing whole genome sequencing and personalised medicine approaches into clinical care (i.e. the United Kingdom’s National Health Service plan to sequence 5 million genomes in 5 years and France and Canada which, at the various stages, are kicking off publicly funded genomic healthcare services), the awareness about the ethical, economic legal and social implication of Personalised MEdicine are becoming central in public discourse.

The Workshop will focus on the discussion on the main challenges and opportunities that emerged during the Conference on “Tackling ethical, economical, legal and social aspects of Personalised Medicine”, stressing on a regional perspective when it comes the potential solution to tackle the identified barriers. The aim is to enable a structured exchange among EU regional stakeholders, the entities which can contribute to the alignment and implementation of Personalised Medicine (PM) and health principles in terms of policy, investments and governance. In this frame, a list of priority actions shall be elaborated and then communicated and disseminated in Europe.

Check out the registration of the conference at the following links.

Day 1:

Day 2: